Development of Advanced Healthcare Systems in Australia. Professor Stephen Smith Dean

Transcription

1 Development of Advanced Healthcare Systems in Australia Professor Stephen Smith Dean 7 April 2014

2 Global Comparison (2012 Data) Australia Population (millions) 22.3 GDP (US$ billions) GDP per capita (US$) 67,723 GDP (PPP) as share (%) of world total 1.17 United Kingdom Population (millions) 62.7 GDP (US$ billions) 2,440.5 GDP per capita (US$) 38,589 GDP (PPP) as share (%) of world total 2.81 South Korea Population (millions) 49.8 GDP (US$ billions) 1,155.9 GDP per capita (US$) 23,113 GDP (PPP) as share (%) of world total 1.94 Source The Global Competitiveness Report : 2013 World Economic Forum

3 Australia Life expectancy well above OECD Ave.

4 Good outcomes reasonable cost Source Strategic Review of Health and Medical Research, Commonwealth of Australia

5 Our health funding is low Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

6 Disturbing growth in diabetes Source: Diabetes: the silent pandemic and its impact on Australia Baker IDI Heart and Diabetes Institute

7 Health Funding in Australia Source: Administrator National Health Funding Pool Annual Report

8 Out of Pocket expenditure is high Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

9 Australia s research impact is well above world average Source: OECD Science, Technology and Industry Scoreboard 2013

10 How do we perform in research?

11 Leading international authors Source: OECD Science, Technology and Industry Scoreboard 2013

12 Our medical research is highly cited Source Strategic Review of Health and Medical Research, Commonwealth of Australia

13 Rapid increase in regional collaboration Source Strategic Review of Health and Medical Research, Commonwealth of Australia

14 Academic Health Centres in Australia: Current Status No Federal Government position fiscal constraints Some State Government Support Victoria Strong A number of small but effective centres e.g. Paediatrics, Cancer etc. Diamantina Health Partners South Australian Centre in Progress Melbourne Academic Centre for Health Monash Partners Westmead Millennium Institute Image source: virtualanz.net

15 The Melbourne Academic Centre for Health (MACH) MACH A Federated Model 20 Partners Melbourne Academic Centre for Health (Academic Health Science System) Mix of Health Services, Research Institutes and the University A System Focus Melbourne Children s Campus (Centre) Victorian Comprehensive Cancer Centre (VCCC) RVEEH Bionics Institute CERA Other AHSCs Interacts with traditional Academic Health Science Centres

16 Exemplar: Melbourne Children s $1 = $ for every dollar donated a further $6.60 is leveraged $97m turnover 50 fellowship holders

17 Exemplar: Melbourne Genomic Health Alliance The Melbourne Genomics Health Alliance links the clinical, research and teaching strengths of its 7 founding members to integrate genomic medicine into everyday healthcare for the betterment of patients. Draws together University of Melbourne Expertise in: Neurology, Pathology, Paediatrics, Population Health, Oncology, Genetics, Health Informatics, E-Research, Genetic Counselling, Supercomputing, General Practice Victorian Population: 5.8million

18 Partner of the Global Alliance for Genomics and Health The Global Alliance for Genomics and Health was formed to help accelerate the potential of genomic medicine to advance human health. It brings together over 140 leading institutions working in healthcare, research, disease advocacy, life science, and information technology. The partners in the Global Alliance are working together to create a common framework of harmonized approaches to enable the responsible, voluntary, and secure sharing of genomic and clinical data.

19 Victorian Comprehensive Cancer Centre AUD $1 billion Expected to open in cancer researchers Dedicated to integration of cancer research, education, treatment and patient care Peter MacCallum Cancer Centre Melbourne Health The University of Melbourne The Royal Women's Hospital Walter and Eliza Hall Institute of Medical Research The Royal Children s Hospital St Vincent s Hospital Melbourne

20 How do we perform in cancer? Source Data courtesy of the Victorian Comprehensive Cancer Centre (VCCC)

21 Peter Doherty Institute Includes The University of Melbourne Victorian Infectious Diseases Reference Laboratory Victorian Infectious Diseases Service Victorian Life Sciences Computation Initiative Victorian Nosocomial Infection Surveillance System WHO Collaborating Centre for Reference and Research on Influenza AUD $210 Million Opening September expert researchers Dedicated to research excellence, education and training Focus on infection and immunity Includes IBM supercomputing facility

22 Vlsci Victorian Life Sciences Computation Initiative Established 2008 Director Professor Peter R Taylor Location The University of Melbourne Affiliations Victorian Government, The University of Melbourne, Monash University, La Trobe University, IBM Research Collaboratory for Life Sciences, Melbourne Website vlsci.org.au

23 Melbourne Brain Centre Parkville and Heidelberg Now open 700+ researchers AUD $225 Million Australia s largest brain research collaboration Includes The Florey Institute of Neuroscience & Mental Health Melbourne Neuroscience Institute, University of Melbourne The Royal Melbourne Hospital Austin Health

24

25 Melbourne Biomedical Precinct Front door to University New Metro rail station Private sector and government Ambulatory care facilities Clinical trials

26 200 patients participating in a study that tests a cycle of care which includes DNA sequencing (whole exome), targeted analysis and clinical interpretation of results. Exemplar: Melbourne Genomic Health Alliance Patients Diagnosed with one of: Acute Myeloid Lukemia Epilepsy Charcot-Marie-Tooth Disease (a neurological disorder) Hereditary Colorectal Cancer Childhood Sydromes 40University staff involved

27 Expenditure mix Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

28 Expenditure by disease Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

29 Projected health expenditure by impact Source Strategic Review of Health and Medical Research, Commonwealth of Australia

30 How do we perform in medical research? Rank Jiao Tong Clinical Medicine and Pharmacy THE Clinical, Pre-Clinical and Health QS Medicine 1 Harvard Oxford Harvard 2 University of California, San Francisco Harvard Oxford 3 University of Washington Cambridge Cambridge 4 Johns Hopkins Imperial College Stanford 5 Columbia Stanford UCLA 6 Cambridge Columbia Johns Hopkins 7 UCLA Johns Hopkins Yale 8 UT (Southwestern Medical Center Dallas) UCLA 9 Stanford UCL UCSF 10 University of Pittsburgh Duke Imperial College Melbourne (36) Melbourne (16) Melbourne (12) UCL Source Strategic Review of Health and Medical Research, Commonwealth of Australia

31 Expenditure is growing rapidly Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

32 Exemplar: Melbourne Children s

33 Average Cites Per Paper Clinical Medicine ave cites 60 Pharmacology & Toxicology ave cites Biology & Biochemistry ave cites Microbiology ave cites 10 0 Neurosciences & Behavioural Sciences ave cites Harvard University Immunology ave cites Molecular Biology & Genetics ave cites Cambridge University Imperial College London University of Melbourne Psychiatry/Psychology ave cites Oxford University Stanford University Thomson Essential Science Indicators 2003-Jun 2013

34 Expenditure is growing rapidly Source: Australia s Health 2012 report of the Australian Institute of Health and Welfare (AIHW)

35 aa/victorian_life_sciences_computation_ Initiative_%28logo%29.jpg

36